AMLX - Amylyx Pharmaceuticals, Inc.
15.05
0.940 6.246%
Share volume: 1,285,694
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$14.11
0.00
0.00%
Summary score
47%
Profitability
53%
Dept financing
21%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-14.71%
Return on sales
-2077.07%
Return on invested capital
0%
Total debt ratio
15.16%
Debt ratio change over timeo
0%
Current Ratio
7.61%
Quick Ratio
6.12%
Cash Position Ratio
2.95%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-16.09%
Return on sales
6113.38%
Return on invested capital
0%
Total debt ratio
10.57%
Debt ratio change over timeo
0%
Current Ratio
10.81%
Quick Ratio
6.67%
Cash Position Ratio
4.93%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-9.98%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
8.48%
Debt ratio change over time
0%
Current Ratio
13.7%
Quick Ratio
0%
Cash Position Ratio
8.73%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 13.23% | 9.84% | 26.17% |
| Return on assets | -14.71% | 4.59% | 3.2% | 1.81% |
| Return on sales | -2077.07% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 0% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 15.16% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | 0% | -16.59% | -73.52% | 21.11% |
| Dept financing | 4% | 22% | 16% | 50% |
| Current Ratio | 10.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 6.67% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.93% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 9% | 12% | 8% |
| Short-term ratios | AMLX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -16.09% | 5.82% | 4.08% | 0.78% |
| Return on sales | 6113.38% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 25% | 18% | 3% |
| Total debt ratio | 10.57% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 20% | 15% | 25% |
| Current Ratio | 10.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 6.67% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.93% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 8% | 8% | 5% |